Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01647828
Title A Phase 1b/2 Study of OMP-59R5 in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors OncoMed Pharmaceuticals, Inc.
Indications

pancreatic ductal adenocarcinoma

Therapies

Nab-paclitaxel

Gemcitabine

Tarextumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.